After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.
Read More